FOR IMMEDIATE RELEASE
CLEVELAND, OH and EVANS CITY, PA- Edgewater Capital Partners (“Edgewater”) has completed the previously announced acquisition of BASF’s Inorganic Specialties business, which includes the Evans City, Pennsylvania production site and the Specialty Alcoholates, Boranes and Alkali Metals product lines. The Company has been renamed “Callery”, a name that speaks to the innovation and customer focus for which Callery Chemical was known and the best practices established during BASF’s ownership.
Bob Girton, Principal, Edgewater Capital said: “We are grateful for all of the hard work by the Callery team over the last several months in helping us complete the transaction. We are excited to join with them in taking Callery to its next level of success, and build on the business’ commitment to environmental, health and safety, high level of product quality, and industry leading reagent and organometallic technology.”
“Callery represents the legacy company name of a world-class solution provider of specialty reagents sold into a growing pipeline of new products in development within pharmaceuticals, biosciences, agrochemicals, electronics, and niche industrial markets.”
ABOUT EDGEWATER CAPITAL
Edgewater Capital Partners, headquartered in Cleveland, Ohio, is a sector focused private equity firm investing in lower, middle-market performance materials businesses. We have extensive experience and expertise in niche manufacturers of specialty chemicals, pharmaceuticals, and engineered substances. Twenty years of industry specific investing has allowed us to develop a deep understanding of the complexities and nuances common to these businesses. We are strategic, patient capital looking for opportunities to partner with owner-operators, management teams, and employees in developing, enhancing, and growing market leading businesses. Further information at www.edgewatercapital.com
Callery, formally known as BASF’s Inorganic Specialties Business, headquartered in Evans City, Pennsylvania, is the world’s leading expert in organometallic and reagent technologies. Callery prides itself in enabling its customer’s success. From boranes to alcoholates, to custom organometallics, Callery’s world-class combination of innovation, production flexibility, customer service, and supply chain security provides its customers a distinct advantage. Callery’s products have enabled some of the world’s most successful innovations from billion-dollar blockbuster drugs to next-generation OLED’s. How can Callery’s capabilities enable your next big innovation? Further information at www.callery.com